Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia buys ventilators fearing flu pandemic:

This article was originally published in Clinica

Executive Summary

Australia has spent Aus$6.2m (US$4.6m) to purchase 303 ventilators and is negotiating the purchase of 11 more. The investment is to ensure that hospitals have sufficient resources in case of an influenza pandemic, which would produce a high incidence of severe breathing disorders. The machines - some portable and some for use in intensive care units - were sourced from Melbourne-based medtech company Draeger Medical Australia. The further 11 will be portable machines. The number of ventilators given to each state and territory was determined by number of patients. The government has pledged Aus$180m over five years to prepare and respond to the potential threat.

You may also be interested in...



Biogen And Sage On Plans To Build A Brain Franchise Together

The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.

US FDA Allows Dry-Heat Systems For Mask Deep Cleaning

The guidance document allows manufacturers to promote their dry-heat systems for mask bioburden reduction if they meet certain standards.

COVID-19: CMS Allowing Hospital-Level Payments For Home-Based Care

The US Medicare agency is letting ambulatory surgical centers and patient homes be reimbursed as in-patient hospitals for patient care purposes during the pandemic.

Topics

UsernamePublicRestriction

Register

LL010986

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel